Skip to main content

Publications

featured publications
  • Lack of repeatability of radiomic features derived from PET scans: Results from a F-DCFPyL test-retest cohort.

    The Prostate

    Authors: Rudolf A Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Alekandser Kosmala, Markus Essler, Thorsten Derlin, Takahiro Higuchi, Constantin Lapa, Andreas K Buck, Kenneth J Pienta, Martin A Lodge, Mario A Eisenberger, Mark C Markowski, Martin G Pomper, Michael A Gorin, Eric C Frey, Steven P Rowe, Ralph A Bundschuh

    View this publication
  • High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data.

    Clinical nuclear medicine

    Authors: Ralph A Bundschuh, Susanne Lütje, Lena Bundschuh, Constantin Lapa, Takahiro Higuchi, Philipp E Hartrampf, Michael A Gorin, Aleksander Kosmala, Andreas K Buck, Martin G Pomper, Steven P Rowe, Markus Essler, Gabriel T Sheikh, Rudolf A Werner

    View this publication
  • Deep learning enables automated MRI-based estimation of uterine volume also in patients with uterine fibroids undergoing high-intensity focused ultrasound therapy.

    Insights into imaging

    Authors: Maike Theis, Tolga Tonguc, Oleksandr Savchenko, Sebastian Nowak, Wolfgang Block, Florian Recker, Markus Essler, Alexander Mustea, Ulrike Attenberger, Milka Marinova, Alois M Sprinkart

    View this publication
  • Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids.

    Scientific reports

    Authors: Tolga Tonguc, Florian Recker, Judith Ganslmeier, Holger M Strunk, Claus C Pieper, Olga Ramig, Simone Welz, Eva K Egger, Nikola Mutschler, Leonie Warwas, Markus Essler, Alexander Mustea, Rupert Conrad, Milka Marinova

    View this publication
  • Multidisciplinary Postoperative Validation of F-FDG PET/CT Scan in Nodal Staging of Resected Non-Small Cell Lung Cancer.

    Journal of clinical medicine

    Authors: Benedetta Bedetti, Philipp Schnorr, Sarah May, Jürgen Ruhlmann, Hojjat Ahmadzadehfar, Markus Essler, Alexander Quaas, Reinhard Büttner, Joachim Schmidt, Holger Palmedo, Yon-Dschun Ko, Kai Wilhelm

    View this publication
  • Safety and Survival Outcomes of Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior Ra treatment: The RALU Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Authors: Kambiz Rahbar, Markus Essler, Kim M Pabst, Matthias Eiber, Christian la Fougère, Vikas Prasad, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph A Bundschuh, Wolfgang P Fendler, Milena Kurtinecz, Anja Schmall, Frank Verholen, Oliver Sartor

    View this publication
  • Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate.

    Frontiers in oncology

    Authors: Taotao Zhou, Robert Mahn, Christian Möhring, Farsaneh Sadeghlar, Carsten Meyer, Marieta Toma, Barbara Kreppel, Markus Essler, Tim Glowka, Hanno Matthaei, Jörg C Kalff, Christian P Strassburg, Maria A Gonzalez-Carmona

    View this publication
  • Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.

    The Prostate

    Authors: Philipp E Hartrampf, Franz-Xaver Weinzierl, Anna Katharina Seitz, Hubert Kübler, Markus Essler, Andreas K Buck, Rudolf A Werner, Ralph A Bundschuh

    View this publication
  • mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.

    European journal of nuclear medicine and molecular imaging

    Authors: Philipp E Hartrampf, Ralph A Bundschuh, Franz-Xaver Weinzierl, Sebastian E Serfling, Aleksander Kosmala, Anna Katharina Seitz, Hubert Kübler, Andreas K Buck, Markus Essler, Rudolf A Werner

    View this publication
  • A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.

    Frontiers in oncology

    Authors: Yutao Li, Amit Sharma, Xiaolong Wu, Hans Weiher, Dirk Skowasch, Markus Essler, Ingo G H Schmidt-Wolf

    View this publication